Fosaprepitant and Arthropathy - a phase IV clinical study of FDA data

Summary:

Arthropathy is reported as a side effect among people who take Fosaprepitant (fosaprepitant), especially for people who are female, 40-49 old, also take Simponi, and have Rheumatoid arthritis.

The phase IV clinical study analyzes which people have Arthropathy when taking Fosaprepitant. It is created by eHealthMe based on reports of 1,178 people who have side effects when taking Fosaprepitant from the FDA, and is updated regularly.

What is Fosaprepitant?

Fosaprepitant has active ingredients of fosaprepitant. eHealthMe is studying from 1,178 Fosaprepitant users. Check the latest studies of Fosaprepitant.

What is Arthropathy?

Arthropathy is found to be associated with 1,604 drugs and 1,684 conditions by eHealthMe. Check the latest studies of Arthropathy.

On Aug, 11, 2026

1,178 people reported to have side effects when taking Fosaprepitant.
Among them, 47 people (3.99%) have Arthropathy.

Among these 47 people:

What is the gender of people who have Arthropathy when taking Fosaprepitant? *

female: 100 %
male: 0.0 %

What is the age of people who have Arthropathy when taking Fosaprepitant? *

What are other drugs people take besides Fosaprepitant? *

What are other side effects people have besides Arthropathy? *

Hypersensitivity: 47 people, 100.00%
Joint Pain: 47 people, 100.00%
Anti-Cyclic Citrullinated Peptide Antibody Positive: 47 people, 100.00%
Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure): 47 people, 100.00%
Discomfort: 47 people, 100.00%
Duodenal Ulcer Perforation (untreated ulcer can burn through the wall of the stomach): 47 people, 100.00%
Dyspnea (difficult or laboured breathing): 47 people, 100.00%
Fatigue (feeling of tiredness): 47 people, 100.00%
Folliculitis (infection of hair root): 47 people, 100.00%
Gastrointestinal Disorder (functional problems of gastrointestinal tract): 47 people, 100.00%

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 47 people, 100.00%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 14 people, 29.79%
Psoriasis (immune-mediated disease that affects the skin): 14 people, 29.79%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 13 people, 27.66%
Joint Pain: 8 people, 17.02%
Migraine (headache): 1 person, 2.13%
Headache (pain in head): 1 person, 2.13%
Ankylosing Spondylitis (type of arthritis affecting the spine): 1 person, 2.13%

* Approximation only. Some reports may have incomplete information.

Do you take Fosaprepitant and have Arthropathy?

- Check whether Arthropathy is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Fosaprepitant:

Fosaprepitant (1,178 reports)

Arthropathy treatments and more:

Arthropathy (75,984 reports)

Browse all side effects of Fosaprepitant:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Arthropathy:

Arthropathy (1,605 drugs)

Browse all the conditions that are associated with Arthropathy:

Arthropathy (1,684 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on fosaprepitant (the active ingredients of Fosaprepitant) and Fosaprepitant (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.